Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Additional registration fee required

Faculty have requested this content not be shared outside of the session

CME Credit Offered

Abstract Award

Recording available 2/16-5/2

AIUM Credit

Foundation Awardee

Poster Icons

Abstract Award

Foundation Awardee

Poster Session 1

Category: Labor

Poster Session 1

(136) Does Equilibrio Therapy Improve ECV Success? Insights from a CHAID Decision Tree Model

Wednesday, February 11, 2026

10:30 AM - 12:00 PM

Presenting Author(s)

AG

Ariel Gimple, MD

Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center
Tel Aviv, Tel Aviv, Israel

Coauthor(s)

IS

Itay Shavit, MSc

Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center
Tel Aviv, Tel Aviv, Israel
SM

Sharon Maslovitz, MD

Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center
Tel Aviv, Tel Aviv, Israel
Itamar Gilboa, MD

Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center
Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Emmanuel Attali, MD (he/him/his)

Head of Maternal Wards
Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center
Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
YY

Yariv Yogev, MD

Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center Gray Faculty of Medicine, Tel Aviv University, Israel
Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Submitting Author(s)

Daniel Gabbai, MD, MPH

Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center
Lis Hospital for Women’s Health, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Objective:
To evaluate whether equilibrio therapy, a structured therapeutic massage aimed at promoting musculoskeletal and pelvic balance, is associated with increased success rates of external cephalic version (ECV).

Study Design:
This retrospective case-control study was conducted in 2025 at a single university-affiliated tertiary medical center. All women with breech presentation who underwent ECV were included. All ECV procedures were performed by a single experienced obstetrician. Immediately following the procedure, participants were asked whether they had received equilibrio therapy within the preceding week. Maternal and obstetric characteristics were collected and compared between women with successful and unsuccessful ECV outcomes. Univariate analysis and CHAID (Chi-squared Automatic Interaction Detector) decision tree modeling were used to explore predictors of success.

Results:
1. A total of 87 women underwent ECV during the study period. Among them, 51 (58.6%) had a successful procedure, while 36 (41.4%) were unsuccessful.
2. In univariate analysis, equilibrio therapy was not associated with ECV success in the overall cohort. However, nulliparity was significantly associated with ECV failure (75% vs. 38%, p< 0.001), as was higher birthweight (3322 g vs. 2987 g, p< 0.05). No other maternal or obstetric characteristics, including age, gestational age, BMI, or history of cesarean (SPCS), were significantly associated with ECV outcomes.
3. In the CHAID decision tree model, nulliparity was the most significant predictor of ECV failure (adjusted p=0.002). Among multiparous women, equilibrio therapy was associated with a higher ECV success rate (80.0% vs. 64.0%, adjusted p=0.007).

Conclusion:
Equilibrio therapy was associated with increased success rates of ECV among multiparous women. These findings suggest a potential benefit of equilibrio treatment in selected populations; however, further studies with larger sample sizes are needed to validate these results and assess clinical applicability.